WallStreetZenWallStreetZen

NASDAQ: GBIO
Generation Bio Co Stock Forecast, Predictions & Price Target

Analyst price target for GBIO

Based on 2 analysts offering 12 month price targets for Generation Bio Co.
Min Forecast
$5.00+51.52%
Avg Forecast
$7.50+127.27%
Max Forecast
$10.00+203.03%

Should I buy or sell GBIO stock?

Based on 2 analysts offering ratings for Generation Bio Co.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GBIO stock forecasts and price targets.

GBIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-14
lockedlocked$00.00+00.00%2024-05-14

1 of 1

Forecast return on equity

Is GBIO forecast to generate an efficient return?
Company
-31%
Industry
76.1%
Market
79%
GBIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GBIO forecast to generate an efficient return on assets?
Company
-14.31%
Industry
30.96%
GBIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GBIO earnings per share forecast

What is GBIO's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$1.68
Avg 2 year Forecast
-$0.82
Avg 3 year Forecast
-$0.56

GBIO revenue forecast

What is GBIO's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$10.4M+3.98%
Avg 2 year Forecast
$10.8M+8.15%
Avg 3 year Forecast
$11.5M+15.88%
GBIO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GBIO revenue growth forecast

How is GBIO forecast to perform vs Biotechnology companies and vs the US market?
Company
4.84%
Industry
35%
Market
9.85%
GBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GBIO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GBIO$3.30$7.50+127.27%Buy
RZLT$5.48$10.60+93.43%Strong Buy
OMER$3.77N/AN/A
ATAI$1.32$10.50+695.45%Strong Buy
PRLD$4.03$5.33+32.33%Hold

Generation Bio Co Stock Forecast FAQ

Is Generation Bio Co Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: GBIO) stock is to Buy GBIO stock.

Out of 2 analysts, 0 (0%) are recommending GBIO as a Strong Buy, 2 (100%) are recommending GBIO as a Buy, 0 (0%) are recommending GBIO as a Hold, 0 (0%) are recommending GBIO as a Sell, and 0 (0%) are recommending GBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Generation Bio Co stock.

What is GBIO's earnings growth forecast for 2024-2026?

(NASDAQ: GBIO) Generation Bio Co's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.79%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.61%.

Generation Bio Co's earnings in 2024 is -$169,059,000.On average, 4 Wall Street analysts forecast GBIO's earnings for 2024 to be -$111,602,129, with the lowest GBIO earnings forecast at -$156,342,774, and the highest GBIO earnings forecast at -$59,210,668. On average, 4 Wall Street analysts forecast GBIO's earnings for 2025 to be -$54,221,005, with the lowest GBIO earnings forecast at -$84,491,627, and the highest GBIO earnings forecast at -$33,929,708.

In 2026, GBIO is forecast to generate -$37,036,605 in earnings, with the lowest earnings forecast at -$60,541,244 and the highest earnings forecast at -$23,950,382.

What is GBIO's revenue growth forecast for 2024-2026?

(NASDAQ: GBIO) Generation Bio Co's forecast annual revenue growth rate of 4.84% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.

Generation Bio Co's revenue in 2024 is $9,963,000.On average, 3 Wall Street analysts forecast GBIO's revenue for 2024 to be $689,238,782, with the lowest GBIO revenue forecast at $272,768,244, and the highest GBIO revenue forecast at $935,395,490. On average, 2 Wall Street analysts forecast GBIO's revenue for 2025 to be $716,848,251, with the lowest GBIO revenue forecast at $404,495,347, and the highest GBIO revenue forecast at $1,029,201,155.

In 2026, GBIO is forecast to generate $768,075,458 in revenue, with the lowest revenue forecast at $404,495,347 and the highest revenue forecast at $1,131,655,568.

What is GBIO's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GBIO) forecast ROA is -14.31%, which is lower than the forecast US Biotechnology industry average of 30.96%.

What is GBIO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GBIO price target, the average GBIO price target is $7.50, with the highest GBIO stock price forecast at $10.00 and the lowest GBIO stock price forecast at $5.00.

On average, Wall Street analysts predict that Generation Bio Co's share price could reach $7.50 by May 14, 2025. The average Generation Bio Co stock price prediction forecasts a potential upside of 127.27% from the current GBIO share price of $3.30.

What is GBIO's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: GBIO) Generation Bio Co's current Earnings Per Share (EPS) is -$2.55. On average, analysts forecast that GBIO's EPS will be -$1.68 for 2024, with the lowest EPS forecast at -$2.35, and the highest EPS forecast at -$0.89. On average, analysts forecast that GBIO's EPS will be -$0.82 for 2025, with the lowest EPS forecast at -$1.27, and the highest EPS forecast at -$0.51. In 2026, GBIO's EPS is forecast to hit -$0.56 (min: -$0.91, max: -$0.36).

What is GBIO's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GBIO) forecast ROE is -31%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.